WNK4 Gene Pseudohypoaldosteronism type 2B Genetic Test
Welcome to DNA Labs UAE, where we offer the WNK4 Gene Pseudohypoaldosteronism type 2B Genetic Test. This test is designed to analyze the WNK4 gene and detect mutations or variations that may be causing the condition known as pseudohypoaldosteronism, type 2B (PHA2B).
Test Components
The WNK4 Gene Pseudohypoaldosteronism type 2B Genetic Test includes the following components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Hepatology Nephrology Endocrinology Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Before undergoing the WNK4 Gene Pseudohypoaldosteronism type 2B Genetic Test, it is important to provide the clinical history of the patient who is going for the test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with WNK4 Gene Pseudohypoaldosteronism, type 2B NGS Genetic DNA Test gene WNK4.
Test Details
The WNK4 gene is associated with a condition called pseudohypoaldosteronism, type 2B (PHA2B). This genetic disorder affects the kidneys’ ability to regulate salt and potassium levels in the body, leading to symptoms such as high blood pressure, low potassium levels, and metabolic acidosis.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously to identify any mutations or variations in the DNA sequence. In the context of PHA2B, NGS genetic testing can be used to detect mutations in the WNK4 gene that may be causing the condition.
By identifying specific mutations in the WNK4 gene, NGS testing can help confirm a diagnosis of PHA2B and provide valuable information for managing the condition. It can also be used for genetic counseling, as it can determine if an individual is a carrier of the mutation and at risk of passing it on to their children.
Overall, NGS genetic testing for the WNK4 gene in the context of PHA2B can aid in diagnosis, treatment, and genetic counseling for individuals and families affected by this condition.
| Test Name | WNK4 Gene Pseudohypoaldosteronism type 2B Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Hepatology Nephrology Endocrinology Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for WNK4 Gene Pseudohypoaldosteronism, type 2B NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WNK4 Gene Pseudohypoaldosteronism, type 2B NGS Genetic DNA Test gene WNK4 |
| Test Details | The WNK4 gene is associated with a condition called pseudohypoaldosteronism, type 2B (PHA2B). This genetic disorder affects the kidneys’ ability to regulate salt and potassium levels in the body, leading to symptoms such as high blood pressure, low potassium levels, and metabolic acidosis. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously to identify any mutations or variations in the DNA sequence. In the context of PHA2B, NGS genetic testing can be used to detect mutations in the WNK4 gene that may be causing the condition. By identifying specific mutations in the WNK4 gene, NGS testing can help confirm a diagnosis of PHA2B and provide valuable information for managing the condition. It can also be used for genetic counseling, as it can determine if an individual is a carrier of the mutation and at risk of passing it on to their children. Overall, NGS genetic testing for the WNK4 gene in the context of PHA2B can aid in diagnosis, treatment, and genetic counseling for individuals and families affected by this condition. |
